Toll Free: 1-888-928-9744

Global and China Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

Published: Jun 14, 2016 | Pages: 180 | Publisher: QYResearch | Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global Drugs for Treatment of Prostate Cancer market was valued at USD 43.47 Billion in 2015, and is projected to reach USD 52.16 Billion by 2021, at a CAGR of 9.99% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Prostate Cancer in Global market, including Triptorelin, Leuprorelin, Flutamide Tablets, Goserelin, Bicalutamide Tablets, Bicalutamide Capsules, Estramustine Phosphate Capsules, Mitoxantrone, Zytiga and Xtandi, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China, forecast to 2021, from 2015.And Zytiga took up 51.33% market share in 2015.

On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.

On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Prostate Cancer, revenue and market share, for key manufacturers. The main manufacturers as follows: IPSEN, Ferring Pharmaceuticals, Takeda Pharmaceutical Company Limited, Schering-Plough Canada, S.C.SINDAN-PHARMA S.R.L., AstraZeneca, Corden Pharma GmbH, Shanxi Zhendong Pharmaceutical, Pfizer, Johnson, Astellas and so on.

On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China.

On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Prostate Cancer in major applications.

With 180 pages, 216 charts and eight chapters, to display the market present situation and future, clearly and deeply.

 
 Table of Contents
Global and China Drugs for Treatment of Prostate Cancer Research Report to 2021 1 Drugs for Treatment of Prostate Cancer Overview and Each Type 1.1 Product Overview of Prostate Cancer 1.1.1 Definition and Product Scope of Drugs for Prostate Cancer 1.1.2 Global Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021 1.13 China Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021 1.2 Product Segments and Price of Each Type 1.2.1 Product Type of Key Manufacturers 1.2.2 Price List and of Each Type 2015 to 2016 1.2.3 Market Share and Growth Rate of Each Type 1.2.4 Triptorelin and Specification 1.2.5 Leuprorelin and Specification 1.2.6 Flutamide Tablets and Specification 1.2.7 Goserelin and Specification 1.2.8 Bicalutamide Tablets and Specification 1.2.9 Bicalutamide Capsules and Specification 1.2.10 Estramustine Phosphate Capsules and Specification 1.2.11 Mitoxantrone and Specification 1.2.12 Zytiga and Specification 1.2.13 Xtandi and Specification 1.3 Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016 1.3.1 Price List (Interviewed) of Triptorelin by Manufacturers 1.3.2 Price List (Interviewed) of Leuprorelin by Key Manufacturers 1.3.3 Price List (Interviewed) of Flutamide Tablets by Manufacturers 1.3.4 Price List (Interviewed) of Goserelin by Manufacturers 1.3.5 Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 1.3.6 Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 1.3.7 Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 1.3.8 Price List (Interviewed) of Mitoxantrone by Manufacturers 1.3.9 Price List (Interviewed) of Zytiga by Manufacturers 1.3.10 Price List (Interviewed) of Xtandi by Manufacturers 2 Competition Analysis by Manufacturers in Global and China 2.1 Global Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2015 to 2016 2.2 Global Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2015 to 2016 2.3 Global Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 2.4 China Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015 2.5 China Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015 2.6 China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 3 Sales and Revenue Segments of Each Type 2010 to 2015 3.1 Global Sales and Revenue Segments of Each Type 2010 to 2015 3.1.1 Global Sales and Market Share of Each Type 2010 to 2015 3.1.2 Global Sales Growth Rate of Each Type 2015 to 2016 3.1.3 Global Revenue and Market Share of Each Type 2015 to 2016 3.1.4 Global Revenue and Market Share of Each Type 2015 to 2016 3.2 Global Sales and Revenue Segments of Each Type 2015 to 2016 3.2.1 Global Sales and Market Share of Each Type 2015 to 2016 3.2.2 Global Sales Growth Rate of Each Type 2015 to 2016 3.2.3 Global Revenue and Market Share of Each Type 2015 to 2016 3.2.4 Global Revenue and Market Share of Each Type 2015 to 2016 4 Market Segments and Forecast of Drugs for Treatment of Prostate Cancer by Regions 4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021 4.1.1 Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021 4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 4.2 Production and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 4.2.1 Production and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 4.2.2 Production Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 4.3 US Market Forecast to 2021 4.3.1 US Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 4.4 Western Europe Market Forecast to 2021 4.4.1 Western Europe Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 4.5 Emerging Markets Market Forecast to 2021 4.5.1 Emerging Markets Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 4.6 Established ROW Market Forecast to 2021 4.6.1 Established ROW Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 4.7 Russia Market Forecast to 2021 4.7.1 Russia Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 4.8 China Market Forecast to 2021 4.8.1 China Sales (Consumption), Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 5 Raw Materials and Applications 5.1 Key Raw Materials and Price Analysis for Triptorelin 5.1.1 Key Raw Materials for Triptorelin 5.1.2 Price Forecast of Key Raw Materials for Triptorelin 2016 to 2021 5.2 Key Raw Materials and Price Analysis for Leuprorelin 5.2.1 Key Raw Materials for Leuprorelin 5.2.2 Price Forecast of Key Raw Materials for Leuprorelin 2016 to 2021 5.3 Key Raw Materials and Price Analysis for Flutamide Tablets 5.3.1 Key Raw Materials for Flutamide Tablets 5.3.2 Price Forecast of Key Raw Materials for Flutamide Tablets 2016 to 2021 5.4 Key Raw Materials and Price Analysis for Goserelin 5.4.1 Key Raw Materials for Goserelin 5.4.2 Price Forecast of Key Raw Materials for Goserelin 2016 to 2021 5.5 Key Raw Materials and Price Analysis for Bicalutamide Tablets 5.5.1 Key Raw Materials for Bicalutamide Tablets 5.5.2 Price Forecast of Key Raw Materials for Bicalutamide Tablets 2016 to 2021 5.6 Key Raw Materials and Price Analysis for Bicalutamide Capsules 5.6.1 Key Raw Materials for Bicalutamide Capsules 5.6.2 Price Forecast of Key Raw Materials for Bicalutamide Capsules 2016 to 2021 5.7 Key Raw Materials and Price Analysis for Estramustine Phosphate Capsules 5.7.1 Key Raw Materials for Estramustine Phosphate Capsules 5.7.2 Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 2016 to 2021 5.8 Key Raw Materials and Price Analysis for Mitoxantrone 5.8.1 Key Raw Materials for Mitoxantrone 5.8.2 Price Forecast of Key Raw Materials for Mitoxantrone 2016 to 2021 5.9 Key Raw Materials and Price Analysis for Zytiga 5.9.1 Key Raw Materials for Zytiga 5.9.2 Price Forecast of Key Raw Materials for Zytiga 2016 to 2021 5.10 Key Raw Materials and Price Analysis for Xtandi 5.10.1 Key Raw Materials for Xtandi 5.10.2 Price Forecast of Key Raw Materials for Xtandi 2016 to 2021 5.11 Applications of Triptorelin 5.12 Applications of Leuprorelin 5.13 Applications of Flutamide Tablets 5.14 Applications of Goserelin 5.15 Applications of Bicalutamide Tablets 5.16 Applications of Bicalutamide Capsules 5.17 Applications of Estramustine Phosphate Capsules 5.18 Applications of Mitoxantrone 5.19 Applications of Zytiga 5.20 Applications of Xtandi 6 Key Manufacturers Analysis of Drugs for Treatment of Prostate Cancer 6.1 IPSEN 6.1.1 IPSEN Basic Information 6.2.2 Triptorelin (Specification and Price) 6.2.3 Sales Value, Gross Margin 2011-2016 6.1.4 Interviewee, Name and Contact 6.2 Ferring Pharmaceuticals 6.2.1 Company Basic Information 6.2.2 Triptorelin (Specification and Price) 6.2.3 Sales Value, Gross Margin 2011-2016 6.2.4 Interviewee, Name and Contact 6.3 Chengdu Tiantaishan pharmaceutical 6.3.1 Company Basic Information 6.3.2 Triptorelin (Specification and Price) 6.3.3 Sales Value, Gross Margin 2011-2016 6.3.4 Interviewee, Name and Contact 6.4 GeneScience Pharmaceuticals 6.4.1 Company Basic Information 6.4.2 Triptorelin (Specification and Price) 6.4.3 Sales Value, Gross Margin 2011-2016 6.4.4 Interviewee, Name and Contact 6.5 Takeda Pharmaceutical Company Limited 6.5.1 Company Basic Information 6.5.2 Leuprorelin (Specification and Price) 6.5.3 Sales Value, Gross Margin 2011-2016 6.5.4 Interviewee, Name and Contact 6.6 Beijing Biote Pharmaceutical 6.6.1 Company Basic Information 6.6.2 Leuprorelin (Specification and Price) 6.6.3 Sales Value, Gross Margin 2011-2016 6.6.4 Interviewee, Name and Contact 6.7 Livzon Pharmaceutical Group 6.7.1 Company Basic Information 6.7.2 Leuprorelin (Specification and Price) 6.7.3 Sales Value, Gross Margin 2011-2016 6.7.4 Interviewee, Name and Contact 6.8 Schering-Plough Canada 6.8.1 Company Basic Information 6.8.2 Flutamide Tablets (Specification and Price) 6.8.3 Sales Value, Gross Margin 2011-2016 6.8.4 Interviewee, Name and Contact 6.9 JiangSu TASLY DI YI Pharmaceutical 6.9.1 Company Basic Information 6.9.2 Flutamide Tablets (Specification and Price) 6.9.3 Sales Value, Gross Margin 2011-2016 6.9.4 Interviewee, Name and Contact 6.10 Shanghai Fudan Fuhua Pharmaceutical 6.10.1 Company Basic Information 6.10.2 Flutamide Tablets (Specification and Price) 6.10.3 Sales Value, Gross Margin 2011-2016 6.10.4 Interviewee, Name and Contact 6.11 S.C.SINDAN-PHARMA S.R.L. 6.11.1 Company Basic Information 6.11.2 Flutamide Tablets (Specification and Price) 6.11.3 Sales Value, Gross Margin 2011-2016 6.11.4 Interviewee, Name and Contact 6.12 AstraZeneca 6.12.1 Company Basic Information 6.12.2 Goserelin (Specification and Price) 6.12.3 Sales Value, Gross Margin 2011-2016 6.12.4 Interviewee, Name and Contact 6.13 Corden Pharma GmbH 6.13.1 Company Basic Information 6.13.2 Bicalutamide Tablets (Specification and Price) 6.13.3 Sales Value, Gross Margin 2011-2016 6.13.4 Interviewee, Name and Contact 6.14 Shanghai Zhaohui Pharmaceutical 6.14.1 Company Basic Information 6.14.2 Bicalutamide Tablets (Specification and Price) 6.14.3 Sales Value, Gross Margin 2011-2016 6.14.4 Interviewee, Name and Contact 6.15 HISUN Pharmaceutical 6.15.1 Company Basic Information 6.15.2 Bicalutamide Tablets (Specification and Price) 6.15.3 Sales Value, Gross Margin 2011-2016 6.15.4 Interviewee, Name and Contact 6.16 Shanxi Zhendong Pharmaceutical 6.16.1 Company Basic Information 6.16.2 Bicalutamide Capsules (Specification and Price) 6.16.3 Sales Value, Gross Margin 2011-2016 6.16.4 Interviewee, Name and Contact 6.17 Pfizer 6.17.1 Company Basic Information 6.17.2 Estramustine Phosphate Capsules (Specification and Price) 6.17.3 Sales Value, Gross Margin 2011-2016 6.17.4 Interviewee, Name and Contact 6.18 Sichuan sunnyhope pharmaceutical 6.18.1 Company Basic Information 6.18.2 Mitoxantrone (Specification and Price) 6.18.3 Sales Value, Gross Margin 2011-2016 6.18.4 Interviewee, Name and Contact 6.19 Luoxin Group 6.19.1 Company Basic Information 6.19.2 Mitoxantrone (Specification and Price) 6.19.3 Sales Value, Gross Margin 2011-2016 6.19.4 Interviewee, Name and Contact 6.20 Jiangsu Aosaikang Pharmaceutical 6.20.1 Company Basic Information 6.20.2 Mitoxantrone (Specification and Price) 6.20.3 Sales Value, Gross Margin 2011-2016 6.20.4 Interviewee, Name and Contact 6.21 JIANG SU HENG RUI MEDICINE 6.21.1 Company Basic Information 6.21.2 Mitoxantrone (Specification and Price) 6.21.3 Sales Value, Gross Margin 2011-2016 6.21.4 Interviewee, Name and Contact 6.22 Johnson 6.22.1 Company Basic Information 6.22.2 Zytiga (Specification and Price) 6.22.3 Sales Value, Gross Margin 2011-2016 6.22.4 Interviewee, Name and Contact 6.23 Astellas 6.23.1 Company Basic Information 6.23.2 Xtandi (Specification and Price) 6.23.3 Sales Value, Gross Margin 2011-2016 6.23.4 Interviewee, Name and Contact 7 Technology Development Trend 7.1 Manufacturing Process of Drugs for Treatment of Prostate Cancer 7.2 Analysis of Manufacturing Process 7.3 Development Trend 8 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Drugs for Prostate Cancer 14 Figure Global Market Size (Value) of Drugs for Prostate Cancer 2016-2021 14 Figure Global Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 14 Figure China Market Size (Value) of Drugs for Prostate Cancer 2016-2021 14 Figure China Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 15 Table Product Type of Key Manufacturers 15 Table Price List and Forecast of Each Type 15 Table Market Share of Each Type 15 Figure Growth Rate of Each Type 2015 to 2016 16 Figure Picture of Triptorelin 16 Table Specification of Triptorelin 16 Figure Picture of Leuprorelin 16 Table Specification of Leuprorelin 17 Figure Picture of Flutamide Tablets 17 Table Specification of Flutamide Tablets 17 Figure Picture of Goserelin 17 Table Specification of Goserelin 17 Figure Picture of Bicalutamide Tablets 17 Table Specification of Bicalutamide Tablets 17 Figure Picture of Type Bicalutamide Capsules 17 Table Specification of Type Bicalutamide Capsules 18 Figure Picture of Estramustine Phosphate Capsules 18 Table Specification of Estramustine Phosphate Capsules 18 Figure Picture of Mitoxantrone 18 Table Specification of Mitoxantrone 18 Figure Picture of Zytiga 18 Table Specification of Zytiga 18 Figure Picture of Xtandi 19 Table Specification of Xtandi 19 Table Price List (Interviewed) of Triptorelin by Manufacturers 2015 and 2016 19 Table Price List (Interviewed) of Leuprorelin by Manufacturers 2015 and 2016 20 Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 20 Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 21 Table Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 2015 and 2016 21 Table Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 2015 and 2016 22 Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 22 Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 23 Table Price List (Interviewed) of Zytiga Phosphate Capsules by Manufacturers 2015 and 2016 23 Table Price List (Interviewed) of Xtandi Phosphate Capsules by Manufacturers 2015 and 2016 24 Table Global Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2015 to 2016 25 Table Global Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2015 to 2016 25 Table Global Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2015 to 2016 26 Table Global Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2015 to 2016 26 Table Global Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 27 Table China Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 28 Table China Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 28 Table China Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 29 Table China Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 29 Table China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 30 Table Global Sales of Each Type 2010 to 2015 31 Table Global Sales Market Share of Each Type 2010 to 2015 31 Table Global Sales Growth Rate of Each Type 2015 to 2016 31 Table Global Revenue of Each Type 2015 to 2016 32 Table Global Revenue Market Share of Each Type 2015 to 2016 32 Table Global Revenue of Each Type 2015 to 2016 32 Table Global Revenue Market Share of Each Type 2015 to 2016 33 Table China Sales of Each Type 2015 to 2016 33 Table China Sales Market Share of Each Type 2015 to 2016 33 Table Global Sales Growth Rate of Each Type 2015 to 2016 33 Table China Revenue of Each Type 2015 to 2016 34 Table China Revenue Market Share of Each Type 2015 to 2016 34 Table China Revenue of Each Type 2015 to 2016 34 Table China Revenue Market Share of Each Type 2015 to 2016 35 Table Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021 36 Figure Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 37 Table North America Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2015 to 2020 37 Table Europe Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2015 to 2020 38 Table Japan Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 38 Table India Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 39 Table Southeast Asia Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 39 Table China Sales, Production, Import and Export of Drugs for Treatment of Prostate Cancer 2016 to 2021 40 Table Key Raw Materials for Triptorelin 41 Table Price Forecast of Key Raw Materials for Triptorelin 41 Table Key Raw Materials for Leuprorelin 42 Table Price Forecast of Key Raw Materials for Leuprorelin 42 Table Key Raw Materials for Flutamide Tablets 42 Table Price Forecast of Key Raw Materials for Flutamide Tablets 43 Table Key Raw Materials for Goserelin 43 Table Price Forecast of Key Raw Materials for Goserelin 43 Table Key Raw Materials for Bicalutamide Tablets 44 Table Price Forecast of Key Raw Materials for Bicalutamide Tablets 44 Table Key Raw Materials for Bicalutamide Capsules 45 Table Price Forecast of Key Raw Materials for Bicalutamide Capsules 45 Table Key Raw Materials for Estramustine Phosphate Capsules 45 Table Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 46 Table Key Raw Materials for Mitoxantrone 46 Table Price Forecast of Key Raw Materials for Mitoxantrone 47 Table Key Raw Materials for Zytiga 47 Table Price Forecast of Key Raw Materials for Zytiga 47 Table Key Raw Materials for Xtandi 48 Table Price Forecast of Key Raw Materials for Zytiga 48 Table Applications of Triptorelin 48 Table Applications of Leuprorelin 49 Table Applications of Flutamide Tablets 49 Table Applications of Goserelin 49 Table Applications of Bicalutamide Tablets 49 Table Applications of Bicalutamide Capsules 50 Table Applications of Estramustine Phosphate Capsules 50 Table Applications of Mitoxantrone 50 Table Applications of Zytiga 51 Table Applications of Xtandi 51 Table IPSEN Basic Information List 52 Table Specification, Price, Sales Value and Market Share of IPSEN 52 Table Sales Value, Gross Margin and Growth rate of IPSEN 52 Figure Product Sales Value, Growth rate of IPSEN 53 Table Ferring Pharmaceuticals Basic Information List 53 Table Specification, Price, Sales Value and Market Share of Ferring Pharmaceuticals 53 Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals 54 Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals 54 Table Chengdu Tiantaishan pharmaceutical Basic Information List 54 Table Specification, Price, Sales Value and Market Share of Chengdu Tiantaishan pharmaceutical 55 Table Sales Value, Gross Margin and Growth rate of Chengdu Tiantaishan pharmaceutical 55 Figure Product Sales Value, Growth rate of Chengdu Tiantaishan pharmaceutical 55 Table GeneScience Pharmaceuticals Basic Information List 55 Table Specification, Price, Sales Value and Market Share of GeneScience Pharmaceuticals 56 Table Sales Value, Gross Margin and Growth rate of GeneScience Pharmaceuticals 56 Figure Product Sales Value, Growth rate of GeneScience Pharmaceuticals 56 Table Takeda Pharmaceutical Company Limited Basic Information List 57 Table Specification, Price, Sales Value and Market Share of Takeda Pharmaceutical Company Limited 57 Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited 57 Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited 58 Table Beijing Biote Pharmaceutical Basic Information List 58 Table Specification, Price, Sales Value and Market Share of Beijing Biote Pharmaceutical 58 Table Sales Value, Gross Margin and Growth rate of Beijing Biote Pharmaceutical 59 Figure Product Sales Value, Growth rate of Beijing Biote Pharmaceutical 59 Table Livzon Pharmaceutical Group Basic Information List 59 Table Specification, Price, Sales Value and Market Share of Livzon Pharmaceutical Group 60 Table Sales Value, Gross Margin and Growth rate of Livzon Pharmaceutical Group 60 Figure Product Sales Value, Growth rate of Livzon Pharmaceutical Group 60 Table Schering-Plough Canada Basic Information List 60 Table Specification, Price, Sales Value and Market Share of Schering-Plough Canada 61 Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada 61 Figure Product Sales Value, Growth rate of Schering-Plough Canada 61 Table JiangSu TASLY DI YI Pharmaceutical Basic Information List 61 Table Specification, Price, Sales Value and Market Share of JiangSu TASLY DI YI Pharmaceutical 62 Table Sales Value, Gross Margin and Growth rate of JiangSu TASLY DI YI Pharmaceutical 62 Figure Product Sales Value, Growth rate of JiangSu TASLY DI YI Pharmaceutical 62 Table Shanghai Fudan Fuhua Pharmaceutical Basic Information List 63 Table Specification, Price, Sales Value and Market Share of Shanghai Fudan Fuhua Pharmaceutical 63 Table Sales Value, Gross Margin and Growth rate of Shanghai Fudan Fuhua Pharmaceutical 63 Figure Product Sales Value, Growth rate of Shanghai Fudan Fuhua Pharmaceutical 64 Table S.C.SINDAN-PHARMA S.R.L. Basic Information List 64 Table Specification, Price, Sales Value and Market Share of S.C.SINDAN-PHARMA S.R.L. 64 Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. 64 Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. 65 Table AstraZeneca Basic Information List 65 Table Specification, Price, Sales Value and Market Share of Pfizer 65 Table Sales Value, Gross Margin and Growth rate of AstraZeneca 66 Figure Product Sales Value, Growth rate of AstraZeneca 66 Table Corden Pharma GmbH Basic Information List 66 Table Specification, Price, Sales Value and Market Share of Corden Pharma GmbH 67 Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH 67 Figure Product Sales Value, Growth rate of Corden Pharma GmbH 67 Table Shanghai Zhaohui Pharmaceutical Basic Information List 67 Table Specification, Price, Sales Value and Market Share of Shanghai Zhaohui Pharmaceutical 68 Table Sales Value, Gross Margin and Growth rate of Shanghai Zhaohui Pharmaceutical 68 Figure Product Sales Value, Growth rate of Shanghai Zhaohui Pharmaceutical 68 Table HISUN Pharmaceutical Basic Information List 69 Table Specification, Price, Sales Value and Market Share of HISUN Pharmaceutical 69 Table Sales Value, Gross Margin and Growth rate of HISUN Pharmaceutical 69 Figure Product Sales Value (M USD), Growth rate of HISUN Pharmaceutical 70 Table Shanxi Zhendong Pharmaceutical Basic Information List 70 Table Specification, Price, Sales Value and Market Share of Shanxi Zhendong Pharmaceutical 70 Table Sales Value, Gross Margin and Growth rate of Shanxi Zhendong Pharmaceutical 70 Figure Product Sales Value, Growth rate of Shanxi Zhendong Pharmaceutical 71 Table Pfizer Basic Information List 71 Table Specification, Price, Sales Value and Market Share of Pfizer 71 Table Sales Value, Gross Margin and Growth rate of Pfizer 72 Figure Product Sales Value, Growth rate of Pfizer 72 Table Sichuan sunnyhope pharmaceutical Basic Information List 72 Table Specification, Price, Sales Value and Market Share of Sichuan sunnyhope pharmaceutical 73 Table Sales Value, Gross Margin and Growth rate of Sichuan sunnyhope pharmaceutical 73 Figure Product Sales Value, Growth rate of Sichuan sunnyhope pharmaceutical 73 Table Luoxin Group Basic Information List 73 Table Specification, Price, Sales Value and Market Share of Luoxin Group 74 Table Sales Value, Gross Margin and Growth rate of Luoxin Group 74 Figure Product Sales Value, Growth rate of Luoxin Group 74 Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 75 Table Specification, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical 75 Table Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical 75 Figure Product Sales Value, Growth rate of Jiangsu Aosaikang Pharmaceutical 76 Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 76 Table Specification, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE 76 Table Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE 77 Figure Product Sales Value, Growth rate of JIANG SU HENG RUI MEDICINE 77 Table Johnson Basic Information List 77 Table Specification, Price, Sales Value and Market Share of Johnson 78 Table Sales Value, Gross Margin and Growth rate of Johnson 78 Figure Product Sales Value, Growth rate of Johnson 78 Table Astellas Basic Information List 78 Table Specification, Price, Sales Value and Market Share of Astellas 79 Table Sales Value, Gross Margin and Growth rate of Astellas 79 Figure Product Sales Value, Growth rate of Astellas 79



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global dem

Read More...

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...

Global Bio polyethylene terephthalate (PET) market size is likely to be valued at USD 12.6 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing preference of biopolymers in numerous applications coupled with favorable gover

Read More...

Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growi

Read More...

Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected

Read More...
Choose License Type
Single User - US $4200
Multi User - US $8400
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify